These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 18061003

  • 21. Atrioventricular junction ablation and pacemaker implant for atrial fibrillation: still a valid treatment in appropriately selected patients.
    Betts TR.
    Europace; 2008 Apr; 10(4):425-32. PubMed ID: 18339612
    [Abstract] [Full Text] [Related]

  • 22. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation.
    de Voogt W, van Hemel N, de Vusser P, Mairesse GH, van Mechelen R, Koistinen J, van den Bos A, Roose I, Voitk J, Yli-Mäyry S, Stockman D, El Allaf D, Tse HF, Lau CP.
    Europace; 2007 Sep; 9(9):798-804. PubMed ID: 17670782
    [Abstract] [Full Text] [Related]

  • 23. The place of hybrid therapies with drugs to supplement nonpharmacological therapies in atrial fibrillation.
    Govindan M, Catanchin A, Camm AJ.
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):210-21. PubMed ID: 18806601
    [Abstract] [Full Text] [Related]

  • 24. [Destruction of the atrioventricular junction and implantation of synchronized atrial pacemaker in a patient with paroxysmal atrial fibrillation].
    Egorov DF, Vygovskiĭ AB, Podlesov AM, Iashin SM.
    Klin Med (Mosk); 1990 Aug; 68(8):88-9. PubMed ID: 2084383
    [No Abstract] [Full Text] [Related]

  • 25. Who, when and how to rate control for atrial fibrillation.
    Rienstra M, Van Gelder IC.
    Curr Opin Cardiol; 2008 Jan; 23(1):23-7. PubMed ID: 18281823
    [Abstract] [Full Text] [Related]

  • 26. [Non-pharmacological treatment of arterial fibrillation].
    Anfinsen OG.
    Tidsskr Nor Laegeforen; 2000 Oct 10; 120(24):2884-9. PubMed ID: 11143410
    [Abstract] [Full Text] [Related]

  • 27. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N, Silberbauer J, Boodhoo L, Freemantle N, Kamalvand K, O'Nunain S, Hildick-Smith D, Lloyd GW, Patel NR, Paul V.
    Europace; 2007 Sep 10; 9(9):790-7. PubMed ID: 17562750
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials.
    Bradley DJ, Shen WK.
    Heart Rhythm; 2007 Feb 10; 4(2):224-32. PubMed ID: 17275763
    [Abstract] [Full Text] [Related]

  • 31. Atrial fibrillation in the new millennium--the role of pacemaker and defibrillator therapy.
    Mitchell AR.
    Med Sci Monit; 2002 Oct 10; 8(10):RA233-9. PubMed ID: 12388933
    [Abstract] [Full Text] [Related]

  • 32. Rate stabilization by right ventricular apex or His bundle pacing in patients with atrial fibrillation.
    Padeletti L, Fantini F, Michelucci A, Pieragnoli P, Colella A, Musilli N, Ricciardi G, Buhr TA, Valsecchi S.
    Europace; 2005 Sep 10; 7(5):454-9. PubMed ID: 16087109
    [Abstract] [Full Text] [Related]

  • 33. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L, Muto C, Maounis T, Schuchert A, Bongiorni MG, Frank R, Vesterlund T, Brachmann J, Vicentini A, Jauvert G, Tadeo G, Gras D, Lisi F, Dello Russo A, Rey JL, Boulogne E, Ricciardi G, Management of Atrial fibrillation Suppression in AF-HF COmorbidity Therapy Study Group.
    Am Heart J; 2008 Sep 10; 156(3):520-6. PubMed ID: 18760135
    [Abstract] [Full Text] [Related]

  • 34. Registry of Atrial Tachycardia and Atrial Fibrillation Episodes in the cardiac rhythm management device population: the RATE Registry design.
    RATE Steering Committee, RATE Investigators.
    Am Heart J; 2009 Jun 10; 157(6):983-7.e1. PubMed ID: 19464407
    [Abstract] [Full Text] [Related]

  • 35. Nonpharmacological therapies for atrial fibrillation.
    Meshil MA, Bhakta D.
    Cardiovasc Ther; 2010 Oct 10; 28(5):264-77. PubMed ID: 20626756
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Management of atrial fibrillation in the elderly.
    Aronow WS.
    Minerva Med; 2009 Feb 10; 100(1):3-24. PubMed ID: 19182738
    [Abstract] [Full Text] [Related]

  • 38. Heart rate regularisation in patients with permanent atrial fibrillation implanted with a VVI(R) pacemaker.
    Mazzocca G, Giovannini T, Frascarelli F, Fabiani A, Burali A, Giappichini G, Bidi G, Bernabò D, Manfredini E, Corbucci G.
    Europace; 2004 May 10; 6(3):236-42. PubMed ID: 15121077
    [Abstract] [Full Text] [Related]

  • 39. Studying atrial fibrillation: what can we learn from the AFTherapy study?
    Israel CW.
    Europace; 2007 Dec 10; 9(12):1107-9. PubMed ID: 18042618
    [No Abstract] [Full Text] [Related]

  • 40. Management of atrial fibrillation in patients with heart failure.
    Efremidis M, Pappas L, Sideris A, Filippatos G.
    J Card Fail; 2008 Apr 10; 14(3):232-7. PubMed ID: 18381187
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.